|
1
|
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
|
Cancer Res
|
2007
|
1.45
|
|
2
|
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.
|
J Immunol
|
2009
|
1.38
|
|
3
|
IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
|
J Clin Invest
|
2002
|
1.24
|
|
4
|
Large-scale proteomics analysis of human ovarian cancer for biomarkers.
|
J Proteome Res
|
2007
|
1.12
|
|
5
|
Protein expression changes in ovarian cancer during the transition from benign to malignant.
|
J Proteome Res
|
2012
|
1.00
|
|
6
|
Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.
|
Cancer Res
|
2006
|
0.97
|
|
7
|
Successful pregnancy after treatment for ovarian malignant teratoma with growing teratoma syndrome.
|
Fertil Steril
|
2009
|
0.84
|
|
8
|
Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes.
|
Acta Oncol
|
2005
|
0.84
|
|
9
|
HSP60 predicts survival in advanced serous ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.84
|
|
10
|
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer.
|
BMC Clin Pathol
|
2013
|
0.82
|
|
11
|
2-DE protein expression in endometrial carcinoma.
|
Acta Oncol
|
2006
|
0.78
|
|
12
|
Conversion of circulating estrone sulfate to 17beta-estradiol by ovarian tumor tissue: a possible mechanism behind elevated circulating concentrations of 17beta-estradiol in postmenopausal women with ovarian tumors.
|
Gynecol Endocrinol
|
2007
|
0.76
|
|
13
|
[Few but potentially severe injuries following intravaginal slingplasty. Reports to the Personskadereglering AB scrutinized].
|
Lakartidningen
|
2007
|
0.75
|